To cut or not to cut - that is the question: a comparative analysis of long-term follow-up after complete and incomplete electroconization of the cervix due to high-grade squamous intraepithelial lesion.

Autor: Suchońska BE; 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland., Gajewska ME; 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland., Blok JM; 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Aug 15; Vol. 14, pp. 1421738. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024).

Reply to K. P. Dieckmann.

Autor: Schaapveld M; Michael Schaapveld, PhD, Netherlands Cancer Institute, Amsterdam, the Netherlands and Joost M. Blok, MD, University Medical Center Utrecht, Utrecht, the Netherlands., Blok JM; Michael Schaapveld, PhD, Netherlands Cancer Institute, Amsterdam, the Netherlands and Joost M. Blok, MD, University Medical Center Utrecht, Utrecht, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 20; Vol. 39 (15), pp. 1690. Date of Electronic Publication: 2021 Mar 16.

Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.

Autor: Blok JM; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Groot HJ; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Huele EH; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands., de Wit R; Department of Medical Oncology, Erasmus University Hospital, Rotterdam, the Netherlands., Horenblas S; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Groenewegen G; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Bosch JLHR; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands., de Brouwer PJM; Department of Radiation Oncology, Dr Bernard Verbeeten Institute, Tilburg, the Netherlands., van den Berg HA; Catharina Hospital, Eindhoven, the Netherlands., Vanneste BGL; Department of Radiation Oncology, MAASTRO-clinic, Maastricht, the Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center+, Maastricht, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands., Schaapveld M; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Feb 01; Vol. 39 (4), pp. 319-327. Date of Electronic Publication: 2020 Oct 29.

Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancer.

Autor: Kuusk T; Netherlands Cancer Institute, Department of Urology, Amsterdam, the Netherlands; Royal Free Hospital, Department of Urology, Renal Cancer Unit, London, United Kingdom., Zondervan P; Academic Medical Center, Department of Urology, Amsterdam, the Netherlands., Lagerveld B; OLVG, Department of Urology, Amsterdam, the Netherlands., Rosenzweig B; The Chaim Sheba Medical Center, Department of Urology, Ramat Gan, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; The Dr. Pinchas Borenstein Talpiot Medical Leadership Program 2013, The Chaim Sheba Medical Center, Ramat Gan, Israel., Raman A; John Hunter Hospital, Department of Urology, Newcastle, Australia., Blok JM; Netherlands Cancer Institute, Department of Urology, Amsterdam, the Netherlands; University Medical Center Utrecht, Department of Urology, Utrecht, the Netherlands., de Bruijn R; Amstelland Hospital, Department of Urology, Amstelveen, the Netherlands., Graafland N; Netherlands Cancer Institute, Department of Urology, Amsterdam, the Netherlands., Hendricksen K; Netherlands Cancer Institute, Department of Urology, Amsterdam, the Netherlands., Capitanio U; Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Department of Urology, Milan, Italy., Minervini A; Careggi Hospital, University of Florence, Department of Urology, Florence, Italy., Ljungberg B; Umeå University Hospital, Department of Urology, Umeå, Sweden., Horenblas S; Netherlands Cancer Institute, Department of Urology, Amsterdam, the Netherlands., Bex A; Netherlands Cancer Institute, Department of Urology, Amsterdam, the Netherlands; Royal Free Hospital, Department of Urology, Renal Cancer Unit, London, United Kingdom. Electronic address: a.bex@nki.nl.

Publikováno v: Urologic oncology [Urol Oncol] 2020 May; Vol. 38 (5), pp. 521-525. Date of Electronic Publication: 2020 Mar 03.

Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease.

Autor: Blok JM; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Vegt E; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Brouwer OR; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Meijer RP; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Bosch JLHR; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Bex A; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Horenblas S; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publikováno v: BJU international [BJU Int] 2019 Sep; Vol. 124 (3), pp. 424-430. Date of Electronic Publication: 2019 Mar 28.